Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Medicinova Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −1 vs. Q4 2022
- Shares held
- 5.59M
- −620.9K (−10.0%) vs. Q4 2022
- Total value
- $12.1M
- −$658.3K (−5.2%) vs. Q4 2022
- New holders
- 1
- 5 more added
- Sold out
- 2
- 19 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,105,941 | $2.39M | 1.38% | 00.0% | Unchanged |
| BlackRock Inc. | 714,881 | $1.54M | 0.00% | +3,099+0.4% | Added |
| Vanguard Group Inc | 625,831 | $1.35M | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 447,957 | $967.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 437,247 | $944.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 251,941 | $544.0K | 0.00% | +315+0.1% | Added |
| JPMorgan Chase & Co | 176,376 | $381.0K | 0.00% | −72,969−29.3% | Reduced |
| HRT Financial LP | 163,819 | $353.0K | 0.00% | −15,383−8.6% | Reduced |
| Northern Trust Corp | 155,742 | $336.4K | 0.00% | −6,485−4.0% | Reduced |
| UBS Group AG | 145,232 | $313.7K | 0.00% | −9,242−6.0% | Reduced |
| Bridgeway Capital Management, LLC | 145,147 | $313.5K | 0.01% | −50,000−25.6% | Reduced |
| Renaissance Technologies LLC | 144,400 | $312.0K | 0.00% | +2,100+1.5% | Added |
| State Street Corp | 142,298 | $307.4K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 139,100 | $300.5K | 0.00% | −9,300−6.3% | Reduced |
| Bank of America Corp | 134,359 | $290.2K | 0.00% | −42,900−24.2% | Reduced |
| Bank of New York Mellon Corp | 120,200 | $259.6K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 110,036 | $237.7K | 0.00% | +35,031+46.7% | Added |
| Ergoteles LLC | 69,240 | $149.6K | 0.01% | −41,756−37.6% | Reduced |
| Jane Street Group, LLC | 52,223 | $112.8K | 0.00% | −215,601−80.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 43,300 | $93.5K | 0.00% | −1,200−2.7% | Reduced |
| Susquehanna International Group, LLP | 32,180 | $69.5K | 0.00% | −32,176−50.0% | Reduced |
| Capricorn Fund Managers Ltd | 25,379 | $54.8K | 0.02% | −41,337−62.0% | Reduced |
| Goldman Sachs Group Inc | 22,702 | $49.0K | 0.00% | −28,317−55.5% | Reduced |
| Price T Rowe Associates Inc | 20,700 | $45.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 20,529 | $44.0K | 0.00% | −15,629−43.2% | Reduced |
| Citadel Advisors LLC | 19,586 | $42.3K | 0.00% | −21,651−52.5% | Reduced |
| Bank Julius Baer & Co. Ltd, Zurich | 19,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 17,843 | $38.5K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 16,657 | $36.0K | 0.00% | −2,087−11.1% | Reduced |
| Blankinship & Foster, LLC | 15,700 | $33.9K | 0.01% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 14,157 | $31.0K | 0.00% | −9,027−38.9% | Reduced |
| WealthTrust Axiom LLC | 12,500 | $27.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 11,646 | $25.2K | 0.00% | −10,874−48.3% | Reduced |
| Point72 Asset Management, L.P. | 7,675 | $16.6K | 0.00% | +7,675 | New |
| Cubist Systematic Strategies, LLC | 3,476 | $7.51K | 0.00% | −7,052−67.0% | Reduced |
| Cutler Group LP | 2,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 412 | $890 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 339 | $732 | 0.00% | +5+1.5% | Added |
| Northwestern Mutual Wealth Management Co | 305 | $659 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 8 | $17 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,674−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,440−100.0% | Sold out |